Results 21 to 30 of about 16,776 (152)

Prophylactic Antiemetic Effects of Midazolam, Ondansetron and their Combination after Middle Ear Surgery

مجله دانشکده پزشکی اصفهان, 2016
Background: The purpose of the present study was to evaluate the efficacy of midazolam-ondansetron combination in prevention of postoperative nausea and vomiting (PONV) after middle ear surgery and its comparison with using midazolam or ondansetron alone.
Azim Honarmand, Seyed Mohammad Reza Safavi, Mansoureh Chegeni   +2 more
doaj   +3 more sources

Comparison of droperidol and ondansetron prophylactic effect on subarachnoid morphine-induced pruritus

Brazilian Journal of Anesthesiology, 2015
Background and objectives: The prophylactic effect of ondansetron on subarachnoid morphine-induced pruritus is controversial, while evidence suggests that droperidol prevents pruritus.
Fabio Ferreira da Cunha Brião, Marcio Leal Horta, Bernardo Lessa Horta, Guilherme Antônio Moreira de Barros, Ana Paula Behrensdorf, Ingrid Severo, Mariana Antunes Nunes, Roberta Boabaid, André Real   +8 more
doaj   +1 more source

Phenylephrine, ondansetron, or combination of both for prevention of intraoperative nausea and vomiting in patients undergoing lower segment cesarean section: A prospective, double-blind randomized control trial

Bali Journal of Anesthesiology, 2023
Background: Intraoperative nausea and vomiting (IONV) are common complications in patients undergoing lower segment cesarean section (LSCS) under subarachnoid block.
Vikram Bedi, Pratibha Yadav, Bishan Kumar Bairwa, Santosh Choudhary, Naveen Kumar, Gayatri Deshpande   +5 more
doaj   +1 more source

Effects of ondansetron alone and in combination with domperidone in the prevention of chemotherapy-induced nausea and vomiting in breast cancer patients

Bangladesh Journal of Pharmacology, 2007
The efficacy and safety of ondansetron, administered alone and in combination with domperidone to prevent chemotherapy-induced nausea and vomiting of breast cancer patients receiving chemotherapy FAC regimen (5-fluorouracil, adriamycin and ...
Kaberi Das Gupta, A. K. M. Mosharrof Hossain, Abdur Raquib Jaigirdar, Borhan Uddin, Tridiv Choudhury, Dipti Rani Saha   +5 more
doaj   +1 more source

Ondansetron and Hypothermia Induced Cardiac Arrest in a 97-Year-Old Woman: A Case Report

Cardiovascular Innovations and Applications, 2022
Background: Ondansetron and hypothermia are both known to induce bradycardia or QT interval prolongation, thus placing affected patients at risk of cardiac arrest.
Keith Sai Kit Leung, Faareaha Ahmad, Amun Mahmood, Yuki Ka Ling Shum, Ekta Punj, Azam Majeed, Riad Hosein, Anna Hong, Muzaffar Hashmi   +8 more
doaj   +1 more source

Elucidation of the Crystal Structures and Dehydration Behaviors of Ondansetron Salts

Crystals, 2019
In drug development, it is extremely important to evaluate the solubility and stability of solid states and to immediately determine the potential for development.
Ryo Mizoguchi, Hidehiro Uekusa
doaj   +1 more source

The association between ondansetron use and mortality risk of traumatic brain injury patients: a population-based study

Frontiers in Pharmacology
Background:Traumatic brain injury (TBI) patients suffer high risks of mortality. Ondansetron has been verified to be effective in improving the prognosis of some kinds of critically ill patients. We design this study to explore whether ondansetron use is
Ruoran Wang, Jing Zhang, Jianguo Xu, Min He   +3 more
doaj   +1 more source

Effect of ondansetron on prevention of post-induction hypotension in elderly patients undergoing general anesthesia: A randomized, double-blind placebo-controlled clinical trial

Saudi Journal of Anaesthesia, 2015
Background: Elderly patients are susceptible to post-induction hypotension. Volume loading and vasopressors for prevention of hypotension in elderly patients may increase perioperative cardiovascular risks.
Mohammad Golparvar, Mahmoud Saghaei, Mohammad Ali Saadati, Shadi Farsaei   +3 more
doaj   +1 more source

Ondansetron‐induced pseudoallergy with non‐ischemic myocardial injury: A rare case report of Kounis syndrome

Clinical Case Reports, 2022
Ondansetron is an FDA‐approved selective serotonin 5‐HT3 receptor commonly indicated as an anti‐emetic agent for nausea and vomiting. It is rare to observe fatal reactions from ondansetron despite having no allergies or previous exposure.
Eden Firew, Helen Huang, Ayush Anand, Yonathan Aliye Asfaw, Charmy Parikh, Hamza Rafique Khan   +5 more
doaj   +1 more source

Severe acute dystonia induced by ondansetron in a paediatric patient: a case report

Emergency Care Journal
Ondansetron, a 5-HT3 serotonin receptor antagonist, is widely used to manage nausea and vomiting, particularly in postoperative recovery, chemotherapy, and paediatric gastroenteritis.
Kishore Nagaraju, Roshni Balachandran, Srilakshmi Ravindra Bhat, Venkatesh Karkada Srinivas, Srinivasan Ranganathan   +4 more
doaj   +1 more source